Transgene Biotek Share Price

Transgene Biotek

CMP as on23-Sep-22 15:24

₹ 3.21
-0.06 -1.83%


₹ 3.27

Turnover (lac)

Prev. Close

₹ 3.27

Day's Vol (shares)

₹ 9,621

Day's Range

₹ 3.12
₹ 3.27

Transgene Biotek was incorporated as a private limited company in Mar.90 and was converted into a public limited company in Nov.90.The company is engaged in the research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.Transgene Bioteks products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial Area,Bollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.

  • Independent Director

    Sujana Kadiam
  • Company Secretary

    Ankita Jain
  • Independent Director

    Santosh Kumar
  • Chairman & Managing Director

    K Koteswara Rao
  • Independent Director

    Marri Swetha

Registered Office

Plot No 69 & 70 IDA Bollaram,


3rd Flr 306 Rightwin,